Cellyan Biotechnology Co., Ltd

An investment holding company incorporated in the Cayman Islands in 2023, Cellyan Biotechnology operates in the over-the-counter pharmaceutical sector across Hong Kong and Mainland China. The company facilitates OTC pharmaceutical cross-border procurement and distribution, leveraging e-commerce supply chain services to connect pharmaceutical products with end-market participants. The company rebranded from Hong Kong Pharma Digital Technology Holdings Limited to Cellyan Biotechnology Co., Ltd in December 2025.

The company's service portfolio encompasses custom clearance, drug listing facilitation, warehouse management, and logistics operations. These services support e-commerce platform logistics partners, merchants, and pharmaceutical distributors operating in the cross-border OTC pharmaceutical market. The business model centers on streamlining the supply chain for OTC pharmaceutical products moving between Hong Kong and Mainland China through digital and logistics infrastructure.

Cellyan Biotechnology operates with 27 full-time employees and maintains headquarters in Yau Tong, Hong Kong. The company is listed on Nasdaq and classified within the pharmaceutical retail and wholesale sector.